These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23165981)

  • 1. Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial.
    van der Marck MA; Bloem BR; Borm GF; Overeem S; Munneke M; Guttman M
    Mov Disord; 2013 May; 28(5):605-11. PubMed ID: 23165981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT).
    van der Marck MA; Munneke M; Mulleners W; Hoogerwaard EM; Borm GF; Overeem S; Bloem BR;
    Lancet Neurol; 2013 Oct; 12(10):947-56. PubMed ID: 23988337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version.
    Carod-Artal FJ; Martinez-Martin P; Vargas AP
    Mov Disord; 2007 Jan; 22(1):91-8. PubMed ID: 17094102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of acupuncture in the treatment of Parkinson's disease: a double-blind pilot study.
    Cristian A; Katz M; Cutrone E; Walker RH
    Mov Disord; 2005 Sep; 20(9):1185-8. PubMed ID: 15884039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease.
    Carod-Artal FJ; Ziomkowski S; Mourão Mesquita H; Martínez-Martin P
    Parkinsonism Relat Disord; 2008; 14(2):102-8. PubMed ID: 17719828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease.
    Verbaan D; van Rooden SM; Benit CP; van Zwet EW; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2011 Sep; 17(8):632-4. PubMed ID: 21696993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial.
    Eggers C; Dano R; Schill J; Fink GR; Hellmich M; Timmermann L;
    J Neurol; 2018 Apr; 265(4):764-773. PubMed ID: 29392459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caregiver strain in Parkinson's disease: national Parkinson Foundation Quality Initiative study.
    Oguh O; Kwasny M; Carter J; Stell B; Simuni T
    Parkinsonism Relat Disord; 2013 Nov; 19(11):975-9. PubMed ID: 23871587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].
    Martínez-Martín P; Carroza-García E; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
    Rev Neurol; 2009 Jul 1-15; 49(1):1-7. PubMed ID: 19557692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal psychometric attributes, responsiveness, and importance of change: An approach using the SCOPA-Psychosocial questionnaire.
    Martínez-Martin P; Carod-Artal FJ; da Silveira Ribeiro L; Ziomkowski S; Vargas AP; Kummer W; Mesquita HM
    Mov Disord; 2008 Aug; 23(11):1516-23. PubMed ID: 18649392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
    Siderowf A; McDermott M; Kieburtz K; Blindauer K; Plumb S; Shoulson I;
    Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.
    Martinez-Martin P; Visser M; Rodriguez-Blazquez C; Marinus J; Chaudhuri KR; van Hilten JJ; ;
    Mov Disord; 2008 Sep; 23(12):1681-8. PubMed ID: 18709672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease.
    Craig LH; Svircev A; Haber M; Juncos JL
    Mov Disord; 2006 Dec; 21(12):2127-33. PubMed ID: 17044088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the freezing of gait questionnaire in patients with Parkinson's disease.
    Giladi N; Tal J; Azulay T; Rascol O; Brooks DJ; Melamed E; Oertel W; Poewe WH; Stocchi F; Tolosa E
    Mov Disord; 2009 Apr; 24(5):655-61. PubMed ID: 19127595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of deep-brain stimulation for Parkinson's disease.
    Deuschl G; Schade-Brittinger C; Krack P; Volkmann J; Schäfer H; Bötzel K; Daniels C; Deutschländer A; Dillmann U; Eisner W; Gruber D; Hamel W; Herzog J; Hilker R; Klebe S; Kloss M; Koy J; Krause M; Kupsch A; Lorenz D; Lorenzl S; Mehdorn HM; Moringlane JR; Oertel W; Pinsker MO; Reichmann H; Reuss A; Schneider GH; Schnitzler A; Steude U; Sturm V; Timmermann L; Tronnier V; Trottenberg T; Wojtecki L; Wolf E; Poewe W; Voges J;
    N Engl J Med; 2006 Aug; 355(9):896-908. PubMed ID: 16943402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson's disease having undergone DBS-STN: A validation study.
    Soulas T; Storme M; Martínez-Martín P; Pichlak M; Gurruchaga JM; Palfi S; Fénelon G
    Rev Neurol (Paris); 2016; 172(4-5):281-8. PubMed ID: 27158039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle regularity measured by the social rhythm metric in Parkinson's disease.
    Câmara Magalhães S; Vitorino Souza C; Rocha Dias T; Felipe Carvalhedo de Bruin P; de Bruin VM
    Chronobiol Int; 2005; 22(5):917-24. PubMed ID: 16298776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.